Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection

Published:2018-06-29 Issue:9 Volume:38 Page:1552-1561
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Asahina Yasuhiro¹^ORCID,Itoh Yoshito²,Ueno Yoshiyuki³^ORCID,Matsuzaki Yasushi⁴,Takikawa Yasuhiro⁵,Yatsuhashi Hiroshi⁶,Genda Takuya⁷,Ikeda Fusao⁸,Matsuda Takuma⁹,Dvory‐Sobol Hadas¹⁰,Jiang Deyuan¹⁰,Massetto Benedetta¹⁰,Osinusi Anu O.¹⁰,Brainard Diana M.¹⁰,McHutchison John G.¹⁰,Kawada Norifumi¹¹,Enomoto Nobuyuki¹²

Affiliation:

1. Tokyo Medical and Dental University Tokyo Japan

2. Kyoto Prefectural University of Medicine Kyoto Japan

3. Yamagata University Yamagata Japan

4. Tokyo Medical University Ibaraki Medical Center Ibaraki Japan

5. Iwate Medical University Iwate Japan

6. National Hospital Organization Nagasaki Medical Center Nagasaki Japan

7. Juntendo University Shizuoka Hospital Shizuoka Japan

8. Okayama University Okayama Japan

9. Gilead Sciences K.K. Tokyo Japan

10. Gilead Sciences, Inc. Foster City CA USA

11. Osaka City University Osaka Japan

12. University of Yamanashi Yamanashi Japan

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.13685

Reference24 articles.

1. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

2. Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan

3. Spread Times of Hepatitis C Virus Estimated by the Molecular Clock Differ among Japan, the United States and Egypt in Reflection of Their Distinct Socioeconomic Backgrounds

4. Sex- and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000

5. Hepatitis C in 6,865 Patients 65 yr or Older: A Severe and Neglected Curable Disease?

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors;Scientific Reports;2024-07-16

2. Comparison of Glecaprevir/Pibrentasvir and Sofosbuvir/Ledipasvir in Patients with Hepatitis C Virus Genotype 1 and 2 in South Korea;The Korean Journal of Gastroenterology;2024-03-25

3. Efficacy and safety of direct-acting antiviral regimen for patients with hepatitis C virus genotype 2: A systematic review and meta-analysis;2023-03-31

4. Efficacy and Safety of Adding Ribavirin to Direct-Acting Antivirals (DAAs) in Re-Treating Non-Genotype 1 Hepatitis C Infection- a Systematic Review and Meta-Analysis;2023

5. Outcomes of Interferon-free Treatment of Hepatitis C Virus Infection Seven Years after Approval and Problems with Drop out during and after Treatment: A Retrospective, Single-center Study;Internal Medicine;2022-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3